Literature DB >> 1738521

The severely anemic and hydropic isoimmune fetus: changes in fetal hematocrit associated with intrauterine death.

N Radunovic1, C J Lockwood, M Alvarez, D Plecas, U Chitkara, R L Berkowitz.   

Abstract

Hydrops caused by isoimmune hemolytic anemia is frequently associated with fetal death following intrauterine intravascular transfusion. To identify possible predictors of procedure-related fetal death, we examined changes in fetal blood volume and hematocrit resulting from the initial transfusion performed on 19 severely anemic, hydropic fetuses. Seven fetuses (36.8%) died at 24-72 hours after transfusion, but in no case was the procedure associated with fetal distress. There were no significant differences between fetuses who died and those who survived in terms of total volume of blood transfused, volume transfused as a percentage of total fetoplacental blood volume, hematocrit of transfused blood, post-transfusion hematocrit, umbilical vein pH, or gestational age at transfusion. Significant differences were noted between hydropic fetuses who died compared with those who survived in the mean pretransfusion hematocrit, 6.7% (+/- 2.0) versus 8.7% (+/- 1.6) (P = .03), and the relative increase in post- over pre-transfusion hematocrit, 5.5-fold (+/- 1.4) versus 3.5-fold (+/- 0.8) (P = .001). Stepwise logistic regression analysis confirmed that only the relative increase in hematocrit was predictive of fetal loss. Moreover, six of seven fetal deaths occurred when the relative increase in hematocrit was greater than fourfold, whereas ten of 12 surviving fetuses had relative increases of less than fourfold. We conclude that large, acute increases in fetal hematocrit following intrauterine transfusion are associated with substantial mortality in hydropic fetuses.

Entities:  

Mesh:

Year:  1992        PMID: 1738521     DOI: 10.1097/00006250-199203000-00013

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.

Authors:  Kazuya Mimura; Masayuki Endo; Atsushi Takahashi; Yohei Doi; Mikiko Sakuragi; Tomoko Kiyokawa; Hidetoshi Taniguchi; Yasuji Kitabatake; Mika Handa; Takuji Tomimatsu; Yoshiaki Tomiyama; Yoshitaka Isaka; Tadashi Kimura
Journal:  Int J Hematol       Date:  2019-09-19       Impact factor: 2.490

Review 2.  Intrauterine transfusion with red cells and platelets.

Authors:  K J Moise
Journal:  West J Med       Date:  1993-09

3.  An elevated fetal interleukin-6 concentration can be observed in fetuses with anemia due to Rh alloimmunization: implications for the understanding of the fetal inflammatory response syndrome.

Authors:  Edi Vaisbuch; Roberto Romero; Ricardo Gomez; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08-11

4.  Diagnosis and treatment of fetal anemia due to isoimmunization.

Authors:  B Plöckinger; I Strümpflen; J Deutinger; G Bernaschek
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

5.  In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice.

Authors:  S Christopher Derderian; P Priya Togarrati; Charmin King; Patriss W Moradi; Damien Reynaud; Agnieszka Czechowicz; Irving L Weissman; Tippi C MacKenzie
Journal:  Blood       Date:  2014-05-30       Impact factor: 22.113

6.  Fetal Cytokine Balance, Erythropoietin and Thalassemia but Not Placental Malaria Contribute to Fetal Anemia Risk in Tanzania.

Authors:  Edward R Kabyemela; Michal Fried; Jonathan D Kurtis; Gwamaka Moses; J Patrick Gorres; Atis Muehlenbachs; Patrick E Duffy
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.